October 17th 2024
The FDA has extended its review of the sNDA, delaying the previous October 15, 2024, PDUFA date, without providing a new anticipated action date.
History of Hepatocellular Carcinoma Increases Risk of Liver-Related Mortality After SVR
November 13th 2023Results from this prospective study in Japan found older age, history of hepatocellular carcinoma, and decreased albumin level at SVR were significantly associated with liver-related mortality after SVR.
Food Insecurity, Household Income Associated with Risk of NAFLD in Adolescents
November 12th 2023Results presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases highlighted an association between food insecurity and low household income with the risk of NAFLD in adolescents.
Seladelpar Improves Markers of Cholestasis, Pruritus in Patients with PBC
November 12th 2023Phase 3 data presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases demonstrated the safety and efficacy of seladelpar in patients with primary biliary cholangitis through 12 months of treatment.
Assisted Reproductive Technology Safe, Effective for Patients with Chronic Liver Disease
November 11th 2023Data presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases (AASLD) showed similar assisted reproductive technology outcomes for patients with and without chronic liver disease.
Alcohol Use Disorder Diagnosis, Treatment Associated with Decreased Risk of Mortality
October 23rd 2023Presented at ACG 2023, findings from a retrospective cohort analysis revealed patients with ALD diagnosed with and prescribed at least 1 medication for alcohol use disorder had a decreased risk of mortality.